
What We’re Reading: Spending Bill Freeze; Cannabidiol as a Dietary Supplement; COVID-19 Misinformation Punishment
Intraparty disagreements over mifepristone cause pause in spending bill agreement until August recess ends; Officials urge the FDA to regulate cannabidiol as a dietary supplement; State medical boards tasked with protecting Americans frequently failed to stop doctors for COVID-19 misinformation.
Republican Disagreements Halt Spending Bill
Intraparty friction over the abortion pill mifepristone have delayed a plan for House votes on Friday and led GOP heads to push legislation funding the FDA until August recess ends,
Officials Urge FDA to Regulate Cannabidiol
Officials and hemp advocates pressed the FDA to quickly regulate cannabidiol (CBD) products as dietary supplements at a House subcommittee hearing Thursday,
Doctors Spreading COVID-19 Misinformation Rarely Punished
Doctors who endangered patients’ lives by pushing medical misinformation during the COVID-19 pandemic and its aftermath have not encountered sufficient repercussions, according to a Washington Post analysis of disciplinary records from medical boards in every state,
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.